Eris Lifesciences secures ANVISA approval for Ahmedabad manufacturing unit
ANVISA inspection in May 2025 enables Eris Lifesciences’ entry into Brazil’s pharma market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Viranchi Shah on India Pharma Inc’s balancing act between aspirations, expectations and…
Regulatory Watch: Dr Viranchi Shah, spokesperson IDMA, and promotor, Saga Lifesciences
US eosinophilic esophagitis market to reach $1.19 billion by 2030, forecasts GlobalData
Market growth driven by FDA-approved therapies Dupixent, Eohilia, and late-stage pipeline candidate APT-1011, according to…
Akums and Government of Zambia form joint venture to establish pharma manufacturing facility
The facility will produce essential medicines in Zambia and supply neighbouring African countries from 2028
Zydus Lifesciences hosts health symposium on new WHO influenza vaccination guideline for Northern…
Zydus Lifesciences convenes healthcare professionals in Bengaluru to discuss WHO’s updated influenza vaccination recommendations…
Thermo Fisher Scientific to expand biopharma manufacturing infrastructure in India
Company to establish Bioprocess Design Centre and Customer Experience Centre in Hyderabad by 2025 to strengthen India’s biopharma…
Japanese researchers develop cerium-based method to enable multiple chemical reactions in one vessel
A team from Chiba University introduces redox-adaptive auto-tandem catalysis, using cerium to sequentially perform two reactions…
Why pharma needs an HRMS built for continuous learning
In this article, Sonali Chowdhry highlights why the pharmaceutical industry needs a Human Resource Management System (HRMS)…
Trinity Challenge Awards £1 million to projects tackling antibiotic resistance in Africa
Com-WATCH in Nigeria and PADs across five African countries win £500,000 each to improve community access to effective antibiotics…
NITI Aayog highlights rare diseases challenge affecting 90 million Indians at FICCI national…
Stakeholders from government, parliament, industry, and patient groups call for indigenous drug development, stronger registries,…